Kelly MacDonald
CIK 1781117 · SVP and CFO · last filed 2026-02-10
Kelly MacDonald is a SVP and CFO who has filed 22 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for DVAX, was dated Feb 10, 2026. Across all open-market trades the lifetime net is −$456.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $461.8K across reported positions. 12 SEC filings were submitted jointly with IRONWOOD PHARMACEUTICALS INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IRWD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2100 POWELL STREET, SUITE 720
EMERYVILLE, CA 94608
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | SVP and CFO | 0 | $15.50 | $0 | $0 | 11 | 2026-02-10 |
| IRWD | Chief Accounting Officer | 98,680 | $4.68 | $461.8K | -$456.0K | 11 | 2020-12-08 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-10 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | −60,204 | $0 | EDGAR |
| 2025-12-29 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +30,977 | -$555.8K | EDGAR |
| 2025-02-20 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +10,502 | -$64.3K | EDGAR |
| 2025-02-18 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +10,682 | -$67.5K | EDGAR |
| 2025-02-12 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +3,336 | -$26.4K | EDGAR |
| 2024-02-20 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-13 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +2,348 | -$38.3K | EDGAR |
| 2023-03-01 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +2,359 | -$30.8K | EDGAR |
| 2023-02-21 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-14 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.